INDP

Indaptus Therapeutics, Inc.

NasdaqCM · Healthcare

$2.63

+5.20% today

last filing 2026-01-20Pro sees filings in ~15 min

Price

hover · 4 moves explained

No open-market activity

Prices distorted

Reverse-split 3×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what INDP ever actually traded at. The drop is real, but those huge old numbers aren't.

Earnings

Beat 2 of last 4

Earnings per share · actual vs forecast

Q1 '25-77.8%

−$8.96

exp −$5.04

Q2 '25+1.6%

−$9.09

exp −$9.24

Q3 '25+28.5%

−$2.98

exp −$4.17

Q4 '25

−$9.19

exp −$4.36

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-01-22	Ben-Tzvi Avraham	Director	—Direct	25,000	—	—
Grant	2025-12-29	Sassi Nir	Chief Financial Officer	—Direct	26,758	$2.03	$54.3K
Grant	2025-12-29	Meckler Jeffrey A10%	Co-Chief Executive Officer	—Direct	216,617	$2.03	$439.7K
Grant	2025-12-29	Newman Michael James	CSO and Director	—Direct	52,204	$2.03	$106.0K
Grant	2025-12-29	Linscott Walt Addison	Chief Operating Officer	—Direct	54,421	$2.03	$110.5K

Grant

Ben-Tzvi Avraham

Director · 2026-01-22

—

25,000 shares

Grant

Sassi Nir

Chief Financial Officer · 2025-12-29

$54.3K

26,758 @ $2.03

Grant

Meckler Jeffrey A

Co-Chief Executive Officer · 2025-12-29

$439.7K

216,617 @ $2.03

Grant

Newman Michael James

CSO and Director · 2025-12-29

$106.0K

52,204 @ $2.03

Grant

Linscott Walt Addison

Chief Operating Officer · 2025-12-29

$110.5K

54,421 @ $2.03

1 more transaction on ProFull insider transaction history is a Pro feature.

Upgrade →